| Application no. and date | 06776679.0 (espacenet) (Federated) (European Patent Register), 20060808 | | Patent/reg. no. and date | DK/EP 1912626, 20160413 | | Publication date | 20080423 | | Priority no. and date | US 595818 P, 20050808 | | EP pub. no. and date |
EP 1912626 20080423 | | Effective date | | | Applicant/owner | AbbVie Deutschland GmbH & Co KG, Max-Planck-Ring 2a
65205 Wiesbaden, DE | | Applicant ref. no. | P018342EPDK1 EJ/GB | | Inventor | BERNDL, Gunther, Am Dörrling 7
67273 Herxheim am Berg, DE,
MÄGERLEIN, Markus, Alberichstr. 88
68199 Mannheim, DE,
DEGENHARDT, Matthias, Ellerstadtstr. 30
67061 Ludwigshafen-Ruchheim, DE | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 9/14 (2006.01) , A61K 9/16 (2006.01) | | Title | Doseringsformer med forbedret biotilgængelighed | | Int. application no. | EP2006007840 | | Int. publication no. | WO2007017249 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
